$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Under the direction of Dr. Zev Rosenwaks, the Center for Reproductive Medicine (CRM) at NewYork-Presbyterian/Weill Cornell is one of the world's most successful programs specializing in assisted reproductive medicine and infertility. The gift to Weill Cornell Medical College will ensure continued advancement and excellence in the research, education and patient care initiatives in reproductive medicine at Weill Cornell. Research will be conducted with the most advanced technology in a state-of-the-art space that is designed to enhance communication among physician-scientists and encourage interdisciplinary and translational research. At its location in the new Weill Greenberg Center, the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine will provide a special environment for ambulatory care that is designed to greatly enhance the patient's experience. Activities will take place at additional sites, including the Lasdon Biomedical Research Building, the Hamad bin Khalifa Biomedical Research Building, the Helmsley Medical Tower, and facilities in Queens and Westchester County. Mr. Perelman's gift will also support the recruitment of new top-ranked faculty and the establishment of faculty endowment.

"Becoming a parent is one of life's most fulfilling experiences. I want to thank Ronald Perelman for his extraordinary generosity and long-standing support of our IVF program. His gift will give us the opportunity to continue to expand our research efforts and apply the latest discoveries in reproductive medicine to assist the millions of patients who are unable to conceive a child," says Dr. Zev Rosenwaks, the Revlon Distinguished Professor of Reproductive Medicine in Obstetrics and Gynecology at Weill Cornell Medical College and director and physician-in-chief of the Center for Reproductive Medicine (CRM) at NewYork-Presbyterian/Weill Cornell.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian Hospital, and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. NewYork-Presbyterian/Weill Cornell physician-scientists have been responsible for many medical advances -- from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial for gene therapy for Parkinson's disease, the first indication of bone marrow's critical role in tumor growth, and, most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian, which is sixth on the U.S.News & World Report's 2007 list of top hospitals, consistently ranks as one of the top hospitals in the country. Weill Cornell Medical College -- in its commitment to global health and education -- has a strong presence in the countries of Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medical College in Qatar is the first U.S. medical college to offer its medical degree overseas. For more information, visit www.nyp.org and www.med.cornell.edu.